INTRODUCTION
The calcium-lowering property of CT in mammals led to its discovery by Copp and his associates over 25 years ago [1] . Subsequent investigations have shown that the osteoclast [2] [3] [4] [5] and renal tubular cells [6] [7] [8] [9] are major target cells. Nevertheless, a number of other tissues possess CT receptors, including brain [10] [11] [12] , lung [13] , testes [14] , and trout gill [15] as well as cell lines derived from a wide range of neoplasias including human breast [16] , lung [17] , and renal carcinoma [18] , leukaemia [19, 20] , teratocarcinoma [21] and osteogenic sarcoma [22] . However, none of these has provided a substantial source of receptor because of either low specific binding activity, scarcity of tissue, or both.
The placenta contains receptors for several peptide hormones including insulin [23] , epidermal growth factor [24] , the somatomedins [25] [26] [27] and gonadotrophin releasing hormone [28] and has been used as a source of receptor for the purification of several of these. In this study we have identified, and characterized, CT receptors in a human placental membrane fraction. The presence of CT receptors in the placenta supports other evidence (reviewed in [29, 30] ) that CT may be important in foetomaternal calcium metabolism.
MATERIALS AND METHODS Chemicals and hormones
Synthetic human CT (hCT) was provided by Dr. W. Rittel, Ciba Geigy, Basle, Switzerland. Synthetic salmon CT (sCT), porcine CT (pCT), des-Leul6-sCT, des-Phel'6-hCT and [Gly8]hCT were provided by Dr 
Preparation of placental membrane fraction
Placentae were placed on ice immediately after delivery and all subsequent procedures were carried out at 4 'C. The placental membrane fraction was prepared as previously described [31] , and summarized as follows. Parenchymal tissue was dissected free of chorion, amnion, cord, and large blood vessels. The tissue was chopped, blended and subsequently homogenized in 25 mM-Tris/250 mM-sucrose/5 mM-EDTA/0.1 mMphenylmethanesulphonyl fluoride, pH 7.4 and centrifuged at 30000 g for 1 h. This washing step was repeated once more and the membrane fraction was stored in washing buffer at -80 'C. Protein concentrations were assayed by the method of Lowry [32] , using bovine serum albumin as the standard.
125I-sCT binding to placental membranes '25I-sCT was prepared using chloramine-T oxidation and QUSO G32 purification [33] . in 50 mM-Tris, pH 7.0, and then resuspended (1-2 mg of membrane protein/ml) in the same buffer with I mg of bovine serum albumin/ml (assay buffer). Incubations were performed with 125I-sCT alone or together with unlabelled peptides. Non-specific binding was assessed in the presence of excess unlabelled sCT (300 nM). To terminate the reaction, the incubation mixtures were chilled to 0°C and 50-150 ,ul aliquots were layered on 200,l of chilled assay buffer in microcentrifuge tubes which were then centrifuged at 10000 g for 5 min. The pellets were washed once with assay buffer and recovered by the method of Rodbell [34] . Adenylate cyclase activity Adenylate cyclase activity was measured in both the placental membrane fraction prepared as described above and in freshly prepared homogenate. The latter was prepared by homogenization of placental tissue in 25 mM-Tris/30 mM-KCl/4.5 mM-MgSO4/0. 1 mg of bovine serum albumin/ml, pH 7.6, followed by centrifugation at 2000 g for 10 min. Only the white-coloured fraction of the resulting pellet was used. The preparations were incubated with [32P]ATP in an ATP-regenerating system of phosphoenolpyruvate and pyruvate kinase as previously described [36] . Time course of binding and dissociation 125I-sCT binding was time-dependent, increasing to a maximum after 4 h at 22°C (Fig. la) (Fig. lb) . This loss of binding was probably due to proteolysis of 1251I-sCT tracer at this higher temperature, since after 4 h only Bound radioactivity was estimated as described in the Materials and methods section.
660 of radioactivity was precipitated by 50 trichloroacetic acid (compared with 82 % of fresh tracer or tracer incubated with membranes for 4 h at 0°C). Furthermore, at 37°C nonspecific binding was very much greater, exceeding specific binding after 2 h. In view of these undesirable binding characteristics at 37°C, subsequent studies were performed at 22 or 0 'C.
Saturation analysis
Saturation of binding to the CT receptor was demonstrated by incubating placental membranes with increasing concentrations of '25I-sCT at 22 'C (Fig. 2a) . Scatchard analysis [37] of the specific binding data (Fig.  2b) (Fig. 3) des-Phe'6-hCT > [Gly8]hCT) proportional to their known biological potencies [38] and their abilities to compete for sCT binding to various cell lines [33, [39] [40] [41] . hCGRP, which is a weak CT agonist [42] [43] [44] , was a weak competitor at 3 x 10-M. The unrelated peptide hormones hPTH-(1-34), porcine insulin and ACTH-(1-24) did not compete at 3 x 10-6 M, Io-6 M and 3 x 10-M respectively. Photoaffinity labelling SDS/PAGE of extracts of placental membranes that had been photoaffinity labelled with '251-[Argt'1 8, 3-nitrophenylazide-Lys14]sCT revealed a major peak of specifically bound radioactivity at an approximate Mr 85000-90000 (Fig. 4) . It cannot be ruled out that this crosslinked component represents a subunit of a larger receptor complex. CT receptor components of Mr 85000-90000 have been identified on the human lung (BEN) and breast (T47D and MCF7) cancer cell lines using a photoactive sCT probe (sCT derivatized with 4-azido-2-nitroaniline at Gln14) [45, 46] and on isolated rat osteoclasts using chemical cross-linking of sCT with disuccinimidyl suberate [5] . A minor peak of higher-Mr labelling was also seen in the experiment depicted in Fig. 4 . However, the precise Mr of this peak was not determinable on 10%0 acrylamide gels, and in other experiments employing 7.5-150% acrylamide gradient gels it was not seen. Adenylate cyclase activity Placental membranes which had been frozen and thawed and freshly prepared homogenate showed adenylate cyclase activity which was stimulated by GTP ( Homogenate was prepared as described in the Materials and methods section. Aliquots were incubated with and without 300 nM-sCT in the absence or presence of 100 /SM-GTP or 10 gM-GTPyS. Adenylate cyclase activity was measured as described previously [36] .
GTPyS (10-9-10-5 M) and forskolin (10-1-10-5 M). Treatment of either preparation with sCT alone (1-300 nM) had no significant effect in ten separate experiments. However, freshly prepared homogenates simultaneously treated with a high concentration of sCT and either GTP (I0-' M) or GTPyS (10-' M) showed significant stimulation (Fig. 5) .
DISCUSSION
These results demonstrate that the membrane fraction prepared from term human placenta contains CT binding sites that have similar specificity, kinetics and apparent Mr as CT receptors from other sources. Like the CT receptor of other target cells or tissues, the placental CT receptor has a high affinity for salmon CT, the relative binding potencies of CTs derived from other species are maintained and non-related peptides do not bind. Furthermore, the placental receptor displays poorly reversible binding, characteristic of CT binding in all tissues studied [7, 10, 20, 39, 40] .
In the presence ofpoorly reversible binding, calculation of the Kd using Scatchard analysis will only give an approximate result, as we have previously discussed [5, 33, 40, 41] . Even so, it is useful to compare our present results obtained from the placenta with those obtained from other tissues. Reported Kd values range three orders of magnitude from 12 pM in calvarial membranes [8] to 32 nm in testicular membranes [14] , the latter probably being in the non-physiological range. However, the majority of reported Kd values have been in the range 11O pM-2 nM with sources including osteoclasts [5] , renal membranes [8] and various cell lines [22, 39, 40] . Most tissues appear to possess a single class of CT receptors, although a second low-affinity site has been noted by some workers [8, 11, 15, 47] . The reported maximum specific binding activities (Bmax) have ranged from 5 fmol/mg of protein for porcine lung membranes [13] to 190 fmol/mg of protein for rat hypothalamic homogenate [48] . Thus, the affinity of the placental CT receptor (mean Kd 80 + 21 pM, n = 4) is comparable with that of other physiological targets such as osteoclasts [5] .
Although the Bmax (mean 58 + 11 fmol/mg of protein, n = 4) is not as high as that obtained with some other tissues, this disadvantage is compensated for by the ready availability of the tissue.
In the tissues and cells examined previously, CT receptors have been shown to be linked to activation of adenylate cyclase, although in the rat hypothalamus CT causes inhibition of adenylate cyclase [12] . It is not possible to conclude from our results that CT receptors in the placenta are also coupled to adenylate cyclase, since stimulation of the enzyme was only seen with high hormone concentrations in the presence of added GTP or GTPyS. This could be a non-specific effect of the peptide, since dose-responsive effects were not demonstrated. However, the ,B-adrenergic agonist adrenaline (5 x l0-M) produced only a 1.5-fold stimulation of adenylate cyclase in placental membranes when used alone but a 2.5-fold stimulation when used together with GTP (l0-' M) [49] . The question of effects of CT on adenylate cyclase in the placenta requires further study.
The physiological significance of the presence of CT receptors in the placenta remains to be determined. It is well established that plasma calcium levels are higher in the foetus than in the mother [29, 30, 50] due to active transport of calcium by the placenta against a concentration gradient [51, 52] . Furthermore, although there are conflicting data regarding the relative PTH levels in maternal and foetal blood, most investigators agree that CT levels are increased in the human foetus [29] . There is a linear relationship between foetal plasma calcium and foetal CT secretion rate [53] , foetal CT levels are stimulated by calcium infusion [54] [55] [56] , and CT infusion into the foetus lowers the plasma calcium level in most species tested [30] . These data suggest that CT has a role in the control of the foetal calcium level. It is possible that in the foetus, as in post-natal life, CT lowers the calcium level by inhibiting osteoclastic bone resorption. However, the finding of CT receptors in the placenta raises the possibility that CT may also act by direct inhibition of the placental calcium pump. Garel [30] has commented on this possibility as an explanation for the observation that maternal hypercalcaemia is not usually associated with foetal hypercalcaemia. There is evidence that maternal CT levels are also elevated [53, 57, 58] .
Although under certain conditions CT clearly produces hypocalcaemia in mammals, its physiological role in mammalian calcium metabolism remains to be determined. Furthermore, its physiological function(s) in more primitive vertebrates such as Aves and Teleosts, which possess more potent CTs, is even more uncertain. The identification of CT receptors in the placenta highlights the need for further investigation of the role of CT in foeto-maternal physiology.
